Level of evidence used in recommendations by the National Comprehensive Cancer Network (NCCN) guidelines beyond Food and Drug Administration approvals

BACKGROUND: A previous analysis of 113 National Comprehensive Cancer Network(®) (NCCN(®)) recommendations reported that NCCN frequently recommends beyond Food and Drug Administration (FDA)-approved indications (44 off-label recommendations) and claimed that the evidence for these recommendations was...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurzrock, R, Gurski, L A, Carlson, R W, Ettinger, D S, Horwitz, S M, Kumar, S K, Million, L, von Mehren, M, Benson, A B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6857604/
https://www.ncbi.nlm.nih.gov/pubmed/31373348
http://dx.doi.org/10.1093/annonc/mdz232

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6857604/
https://www.ncbi.nlm.nih.gov/pubmed/31373348
http://dx.doi.org/10.1093/annonc/mdz232

Ejemplares similares